|
Volumn 53, Issue 9, 2001, Pages 1287-1294
|
In-vitro and in-vivo immunomodulatory effects of syringin
a b c b d b b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARACHIDONIC ACID;
CD4 ANTIGEN;
CD8 ANTIGEN;
CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE;
CROTON OIL;
FLUORESCEIN ISOTHIOCYANATE;
LIPOPOLYSACCHARIDE;
NITRIC OXIDE;
SYRINGIN;
TUMOR NECROSIS FACTOR ALPHA;
ALLERGY;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL PROLIFERATION;
COMPLEMENT ACTIVATION;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOTOXIC T LYMPHOCYTE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG INHIBITION;
EDEMA;
ENZYME INHIBITION;
GUINEA PIG;
HEMOLYSIS;
IMMUNOMODULATION;
IN VITRO STUDY;
IN VIVO STUDY;
LYMPHOCYTE COUNT;
MALE;
MOUSE;
NONHUMAN;
SHEEP ERYTHROCYTE;
|
EID: 0034813455
PISSN: 00223573
EISSN: None
Source Type: Journal
DOI: 10.1211/0022357011776577 Document Type: Article |
Times cited : (89)
|
References (31)
|